Other disclosuresNSE · SUNPHARMA
Sun Pharmaceutical Industries Limited
Press Release
01 / The disclosure
What the company shared
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled "New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026".
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106805144
- First collected
- 3 Oct 2026, 17:17 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.